Simultaneous kidney-pancreas transplantation without antilymphocyte induction

Transplantation

Volumn 69, Issue 1, 2000, Pages 49-54

  Reddy, K Sudhakar ^a   Stratta, Robert J ^b   Shokouh Amiri, Hosein ^b   Alloway, Rita ^b   Somerville, Troy ^b   Egidi, M Francesca ^b   Gaber, Lillian W ^b   Gaber, A Osama ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PANCREAS FUNCTION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 0034650480     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200001150-00010     Document Type: Article

References (24)

1. Stratta RJ, Larsen JL, Cushing K. Pancreas transplantation for diabetes mellitus. Annu Rev Med 1995; 46: 281.
2. Gruessner AC, Sutherland DER. Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory, 1998: 45.
3. Amend WJC, Gjertson DW, Cecka JM. Primary disease effects and associations in patients without early post-transplant events. Clinical Transplants 1995. In: Cecka JM, Terasaki PI, eds. Los Angeles: UCLA Tissue Typing Laboratory, 1996; 395.
4. Sollinger HW, Odorico JS, Knechtle SJ, D'Alessandro AM, Kalayoglu M, Pirsch JD. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998; 228: 284.
5. Stratta RJ. Immunosuppression in pancreas transplantation: progress, problems, and perspective. Transplant Immunol 1998; 6: 69.
6. Stratta RJ, Gaber AO, Shikouh-Amiri MH, Reddy S, Elmer D. A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation. Proceedings of the 24th Annual Scientific Meeting of the American Society of Transplant Surgeons, Chicago, IL: May 13-15, 1998.
7. Gaber AO, Shokouh-Amiri MH, Grewal HP, et al. A technique for portal pancreas transplantation with enteric drainage. Surg Gynecol Obstet 1993; 177: 417.
8. Stratta RJ. Gancyclovir/acyclovir and fluconazole prophylaxis after simultaneous kidney-pancreas transplantation. Transplant Proc 1998; 30: 262.
9. Somerville T, Hurst G, Alloway R, et al. Superior efficacy of oral Ganciclovir over oral Acyclovir for CMV prophylaxis in kidney/ pancreas and pancreas alone recipients. Transplant Proc 1998; 30: 1546.
10. Nymann T, Hathaway DK, Shokouh-Amiri MH, et al. Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation. Clin Transplant 1998; 12: 175.
11. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histological diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
12. Brayman KL, Egidi MF, Naji AL, et al. Is induction therapy necessary for successful simultaneous panceas and kidney transplantation in the cyclosporine era? Transplant Proc 1994; 26: 2525.
13. Sutherland DER, Moudry-Munns KC, Gruessner A. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine. Transplant Proc 1994; 26: 2752.
14. Wadstrom J, Brekke B, Wramner L, Ekberg H, Tyden G. Triple versus quadruple induction immunosuppression in pancreas transplantation. Transplant Proc 1995; 27: 1317.
15. Shapiro ME, Abrams JM, Brown RS, Steinman TI, Strom TB. Successful pancreas-renal transplantation without anti-T-cell antibody induction. Transplant Proc 1995; 27: 3087.
16. Gruessner RWG, Burke GW, Stratta RJ, et al. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 1996; 61: 261.
17. Odorico JS, Pirsch JD, Knetchtle SJ, et al. A study comparing Mycophenolate Mofetil to Azathioprine in simultaneous pancreas-kidney transplantation Transplantation 1998; 66: 1751.
18. Stratta RJ for the FK/MMF multi-center study group. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients. A multicenter report. Transplant Proc 1997; 29: 654.
19. Schulz T, Martin D, Heimes M, Klempnauer J, Busing M. Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. Transplant Proc 1998; 30: 1533.
20. Corry RJ, Shapiro R, Egidi MF, et al. Pancreas transplantation without antibody therapy. Transplant Proc 1998; 30: 299.
21. Jordan ML, Shapiro R, Gritsch HA, et al. Long-term results of pancreas transplantation under Tacrolimus immunosuppression. Transplantation 1999; 67: 266.
22. Burke GW, Ciancio G, Alejandro R, et al. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. Transplant Proc 1998; 30: 1544.
23. Kaufman DB, Leventhal JR, Stuart J, Abecassis M, Fryer JP, Stuart FP. Mycophenolate mofetil (MMF) and tacrolimus (TAG) as primary maintainance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. Transplantation 1999; 67: 586.
24. Zucker K, Rosen A, Tsaroucha A, et al. Unexpected augmentation of Mycophenolic acid pharmacokinetics in renal transplant patients receiving Tacrolimus and Mycophenolate Mofetil in combination therapy and analogous in vitro findings. Transplant Immunol 1997; 5: 225.